Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 5M | 6M | 11M | 4M | 3M | 3M |
| Cost of revenue | 3M | 3M | 10M | 2M | 1M | 1M |
| Gross profit | 3M | 3M | 862,879 | 1M | 1M | 1M |
| Research and development | 503,046 | 699,319 | 658,795 | 739,673 | 572,422 | 460,122 |
| Selling, general and administrative | 4M | 2M | 2M | 2M | 2M | 2M |
| Operating expenses | 4M | 3M | 3M | 3M | 2M | 3M |
| Operating income | −2M | −221,256 | −2M | −2M | −1M | −2M |
| Pre-tax income | −2M | −188,373 | −2M | −2M | −1M | −2M |
| Net income | −2M | −188,373 | −2M | −2M | −1M | −2M |
| Earnings per share | −0.06 | −0.01 | −0.09 | −0.09 | −0.12 | −0.16 |
| Earnings per share, diluted | −0.06 | −0.01 | −0.09 | −0.09 | −0.12 | −0.16 |
| Weighted average shares | 24M | 21M | 20M | 20M | 10M | 10M |
| Weighted average shares, diluted | 24M | 21M | 20M | 20M | 10M | 10M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 12M | 5M | 8M | 11M | 17M | 19M | 1M | 1M |
| Short-term investments | 7M | — |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | −3M | — | — | −2M | — | — |
| Depreciation and amortisation | 532,384 | 381,094 | 256,158 | 122,060 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| — |
| — |
| — |
| — |
| — |
| — |
| Receivables | 4M | 3M | 3M | 5M | 2M | 1M | 1M | 1M |
| Inventory | 10M | 9M | 9M | 8M | 7M | 8M | 8M | 8M |
| Current assets | 33M | 25M | 22M | 25M | 27M | 28M | 13M | 12M |
| Property, plant and equipment | 3M | 3M | 3M | 3M | 3M | 2M | 2M | 2M |
| Goodwill | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M |
| Total assets | 60M | 51M | 47M | 49M | 42M | 43M | 28M | 25M |
| Current liabilities | 8M | 15M | 8M | 9M | 2M | 2M | 3M | 2M |
| Total liabilities | 11M | 19M | 11M | 13M | 6M | 6M | 7M | 5M |
| Equity | 48M | 33M | 36M | 36M | 36M | 37M | 20M | 21M |
| Shares outstanding | 25M | 21M | 21M | 21M | 20M | 20M | 11M | 10M |
| Shares issued | 25M | 21M | 21M | 21M | 20M | 20M | 11M | 10M |
| 130,145 |
| 129,322 |
| Share-based compensation | 632,610 | — | — | 125,086 | — | — |
| Capital expenditure | — | — | — | 361,045 | — | — |
| Investing cash flow | −7M | — | — | −361,045 | — | — |
| Financing cash flow | 10M | — | — | −3,791 | — | — |